Literature DB >> 17610417

Butyrophilin-like 2 gene is associated with ulcerative colitis in the Japanese under strong linkage disequilibrium with HLA-DRB1*1502.

A Mochida1, Y Kinouchi, K Negoro, S Takahashi, S Takagi, E Nomura, Y Kakuta, M Tosa, T Shimosegawa.   

Abstract

The human leukocyte antigen (HLA) region has been implicated in the pathogenesis of inflammatory bowel disease (IBD), which is classified into Crohn's disease (CD) and ulcerative colitis (UC). Recently, an association between sarcoidosis and the butyrophilin-like 2 (BTNL2) gene was reported. BTNL2 is located in the HLA region and its messenger RNA is expressed most abundantly in the intestine. In this study, we performed a case-control association study of BTNL2 in the Japanese patients with IBD and performed linkage disequilibrium (LD) analysis between BTNL2 and HLA-DRB1. We analyzed eight polymorphisms selected after direct sequencing and found that none of the polymorphisms were associated with the Japanese CD cohort. In contrast, five polymorphisms were significantly associated with UC, especially three single nucleotide polymorphisms (BTNL2_19, BTNL2_22 and BTNL2_23) were associated as a haplotype. The most frequent haplotype (GGC haplotype) was a low-risk haplotype (P= 0.000052), whereas the other TCT haplotype was a high-risk haplotype (P= 0.0000085). Among the eight polymorphisms, the strongest association with UC was found in BTNL2_19 (OR = 1.92, P= 0.0000035). As expected, the BTNL2_19-T allele showed strong LD with DRB1*1502 (D'= 0.92). When BTNL2_19 was tested as conditional on the DRB1*1502 carrier status, the significant association disappeared, suggesting that the association was because of its strong LD with DRB1*1502. We conclude that BTNL2 does not contribute to the susceptibility to Japanese CD but is associated with Japanese UC because of the strong LD with HLA-DRB1*1502. The strong LD between BTNL2 and HLA-DRB1 raises another issue about the potential role of BTNL2 in other diseases associated with HLA-DRB1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17610417     DOI: 10.1111/j.1399-0039.2007.00866.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  16 in total

Review 1.  Epithelial decision makers: in search of the 'epimmunome'.

Authors:  Mahima Swamy; Colin Jamora; Wendy Havran; Adrian Hayday
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

Review 2.  Gatekeepers of intestinal inflammation.

Authors:  Heather A Arnett; Joanne L Viney
Journal:  Inflamm Res       Date:  2010-01       Impact factor: 4.575

3.  BTNL2-Ig Protein Attenuates Type 1 Diabetes in Non-Obese Diabetic (NOD) Mice.

Authors:  Xiaohong Tian; Yujun Lin; Cheng Cui; Min Su; Laijun Lai
Journal:  Adv Healthc Mater       Date:  2019-03-18       Impact factor: 9.933

Review 4.  Immune modulation by butyrophilins.

Authors:  Heather A Arnett; Joanne L Viney
Journal:  Nat Rev Immunol       Date:  2014-08       Impact factor: 53.106

5.  Association of a polymorphism of BTN2A1 with chronic kidney disease in individuals with or without hypertension or diabetes mellitus.

Authors:  Tetsuro Yoshida; Kimihiko Kato; Mitsutoshi Oguri; Hideki Horibe; Toshiki Kawamiya; Kiyoshi Yokoi; Tetsuo Fujimaki; Sachiro Watanabe; Kei Satoh; Yukitoshi Aoyagi; Masashi Tanaka; Hiroto Yoshida; Shoji Shinkai; Yoshinori Nozawa; Yoshiji Yamada
Journal:  Exp Ther Med       Date:  2011-01-13       Impact factor: 2.447

6.  Butyrophilin-like 1 encodes an enterocyte protein that selectively regulates functional interactions with T lymphocytes.

Authors:  Anna Bas; Mahima Swamy; Lucie Abeler-Dörner; Gareth Williams; Dick J Pang; Susannah D Barbee; Adrian C Hayday
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-28       Impact factor: 11.205

7.  Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.

Authors:  Gideon M Hirschfield; Xiangdong Liu; Chun Xu; Yue Lu; Gang Xie; Yan Lu; Xiangjun Gu; Erin J Walker; Kaiyan Jing; Brian D Juran; Andrew L Mason; Robert P Myers; Kevork M Peltekian; Cameron N Ghent; Catalina Coltescu; Elizabeth J Atkinson; E Jenny Heathcote; Konstantinos N Lazaridis; Christopher I Amos; Katherine A Siminovitch
Journal:  N Engl J Med       Date:  2009-05-20       Impact factor: 91.245

8.  In vivo administration of recombinant BTNL2-Fc fusion protein ameliorates graft-versus-host disease in mice.

Authors:  Cheng Cui; Xiaohong Tian; Yujun Lin; Min Su; Qingquan Chen; Shao-Yuan Wang; Laijun Lai
Journal:  Cell Immunol       Date:  2018-10-26       Impact factor: 4.868

9.  Association of Clinical Features with Human Leukocyte Antigen in Japanese Patients with Ulcerative Colitis.

Authors:  Taku Iwamoto; Kazuo Yashima; Keiko Morio; Naoki Ueda; Yuichiro Ikebuchi; Koichiro Kawaguchi; Kenichi Harada; Hajime Isomoto
Journal:  Yonago Acta Med       Date:  2018-03-28       Impact factor: 1.641

10.  Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease.

Authors:  Sheila A Fisher; Mark Tremelling; Carl A Anderson; Rhian Gwilliam; Suzannah Bumpstead; Natalie J Prescott; Elaine R Nimmo; Dunecan Massey; Carlo Berzuini; Christopher Johnson; Jeffrey C Barrett; Fraser R Cummings; Hazel Drummond; Charlie W Lees; Clive M Onnie; Catherine E Hanson; Katarzyna Blaszczyk; Mike Inouye; Philip Ewels; Radhi Ravindrarajah; Andrew Keniry; Sarah Hunt; Martyn Carter; Nick Watkins; Willem Ouwehand; Cathryn M Lewis; Lon Cardon; Alan Lobo; Alastair Forbes; Jeremy Sanderson; Derek P Jewell; John C Mansfield; Panos Deloukas; Christopher G Mathew; Miles Parkes; Jack Satsangi
Journal:  Nat Genet       Date:  2008-04-27       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.